All Stories

  1. Comparing self‐report medication data from a longitudinal study on intellectual disability and national dispensing records

    Article • Journal of Intellectual Disability Research, October 2024, Wiley

    Dr martin c henman

  2. OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability

    Article • Expert Review of Clinical Pharmacology, August 2024, Taylor & Francis

    Dr martin c henman

  3. Psychotropic medicines’ prevalence, patterns and effects on cognitive and physical function in older adults with intellectual disability in Ireland: longitudinal cohort study, 2009–2020

    Article • BJPsych Open, February 2024, Royal College of Psychiatrists

    Dr martin c henman

  4. Council of Europe Resolution on the Implementation of Pharmaceutical Care—A Step Forward in Enhancing the Appropriate Use of Medicines and Patient-Centred Care

    Article • Healthcare, January 2024, MDPI AG

    Dr martin c henman

  5. Scope, content and quality of clinical pharmacy practice guidelines: a systematic review

    Article • International Journal of Clinical Pharmacy, November 2023, Springer Science + Business Media

    Dr martin c henman

  6. Examining Quality, Use and Impact of Psychotropic (Use) in older adults with intellectual disabilities (EQUIP): study protocol

    Article • HRB Open Research, November 2023, Faculty of 1000, Ltd.

    Dr martin c henman

  7. Prescriber’s view on anticholinergic deprescribing among older adults with intellectual disability: A qualitative study protocol

    Article • HRB Open Research, August 2023, Faculty of 1000, Ltd.

    Dr martin c henman

  8. Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries

    Article • International Journal of Clinical Pharmacy, June 2023, Springer Science + Business Media

    Dr martin c henman

  9. How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy

    Article • International Journal of Clinical Pharmacy, March 2023, Springer Science + Business Media

    Dr martin c henman

  10. Evidence of Mental Health Support and the Pharmacist

    Article • January 2023, Springer Science + Business Media

    Dr martin c henman

  11. Examining Quality, Use and Impact of Psychotropic (Use) in older adults with intellectual disabilities (EQUIP): study protocol

    Article • HRB Open Research, November 2022, Faculty of 1000, Ltd.

    Dr martin c henman

  12. The adverse effects of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review

    Article • HRB Open Research, September 2022, Faculty of 1000, Ltd.

    Dr martin c henman

  13. Online and Blended Learning Courses for Healthcare Professionals and Policymakers on Patients’ Perspectives on Medicine: A Project Report

    Article • Pharmacy, March 2022, MDPI AG

    Dr martin c henman

  14. The relationship between antiepileptic drug load and challenging behaviors in older adults with intellectual disability and epilepsy

    Article • Epilepsy & Behavior, September 2021, Elsevier

    Dr martin c henman

  15. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries

    Article • Research in Social and Administrative Pharmacy, August 2021, Elsevier

    Dr martin c henman

  16. Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy

    Article • International Journal of Clinical Pharmacy, July 2021, Springer Science + Business Media

    Filipa Costa, Dr martin c henman

  17. The impact of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review protocol

    Article • HRB Open Research, June 2021, Faculty of 1000, Ltd.

    Dr martin c henman

  18. Antiepileptic drugs, occurrence of seizures and effect of co‐administration of potential seizure threshold‐lowering psychotropic drugs in adults with intellectual disability who have epilepsy

    Article • Journal of Applied Research in Intellectual Disabilities, February 2021, Wiley

    Dr martin c henman

  19. Experiences of the Medication Use Process by People with Intellectual Disabilities. What a Pharmacist Should Know!

    Article • Pharmacy, January 2021, MDPI AG

    Bernadette Flood, Dr martin c henman

  20. Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives

    Article • Therapeutic Advances in Drug Safety, January 2021, SAGE Publications

    Dr martin c henman

  21. Primary Health Care and Community Pharmacy in Ireland: a lot of visions but little progress

    Article • Pharmacy Practice, November 2020, JCFCorp SG PTE LTD

    Dr martin c henman

  22. Impact of a global leader on pharmaceutical practice and policy around the world

    Article • Journal of Pharmaceutical Policy and Practice, August 2020, Taylor & Francis

    Filipa Costa, Dr martin c henman

  23. Pharmacy Education; Competency and Beyond

    Article • Pharmacy, June 2020, MDPI AG

    Dr martin c henman

  24. A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers

    Article • International Journal of Clinical Pharmacy, May 2020, Springer Science + Business Media

    Dr martin c henman

  25. Measuring drug burden in older adults with intellectual disabilities: Critical issues for consideration in finding the optimal measure to improve safety of medicines use

    Article • Expert Opinion on Drug Safety, April 2020, Taylor & Francis

    Dr martin c henman

  26. Medication burden and frailty in older adults with intellectual disability: An observational cross‐sectional study

    Article • Pharmacoepidemiology and Drug Safety, March 2020, Wiley

    Dr martin c henman

  27. Laxative use among older adults with intellectual disability: a cross-sectional observational study

    Article • International Journal of Clinical Pharmacy, December 2019, Springer Science + Business Media

    Dr martin c henman

  28. 18 A Review of Interventions to Improve Medication Adherence in Patients with Parkinson’s Disease

    Article • Age and Ageing, September 2019, Oxford University Press (OUP)

    Dr martin c henman

  29. Design and Implementation of an Integrated Competency-Focused Pharmacy Programme: A Case Report

    Article • Pharmacy, August 2019, MDPI AG

    Assoc. Prof. Sheila A. Ryder, Dr martin c henman

  30. Association of Drug Burden Index with grip strength, timed up and go and Barthel index activities of daily living in older adults with intellectual disabilities: an observational cross-sectional study

    Article • BMC Geriatrics, June 2019, Springer Science + Business Media

    Dr martin c henman

  31. Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities

    Article • Journal of Applied Research in Intellectual Disabilities, April 2019, Wiley

    Dr martin c henman

  32. 82Secondary Prevention Post-Hip Fracture – Is Treatment Optimised?

    Article • Age and Ageing, September 2018, Oxford University Press (OUP)

    Dr martin c henman

  33. 125Use of the Sedative Load Model in Older Adults with Intellectual Disabilities

    Article • Age and Ageing, September 2018, Oxford University Press (OUP)

    Dr martin c henman

  34. Medication use and whether it is appropriate in older people with intellectual disability

    Article • Therapeutic Advances in Drug Safety, June 2018, SAGE Publications

    Maire O'Dwyer, Dr martin c henman

  35. Medication Use and Health Screening in an Ageing Adult Population With Down Syndrome in Ireland: A Descriptive Study

    Article • Journal of Policy and Practice in Intellectual Disabilities, June 2018, Wiley

    Dr martin c henman

  36. The use of drugs to suppress excess stomach acid in older people with intellectual disability.

    Article • Saudi Pharmaceutical Journal, May 2018, Elsevier

    Dr martin c henman

  37. Measurement of the use of high risk drugs in older people with intellectual disabilities.

    Article • British Journal of Clinical Pharmacology, January 2018, Wiley

    Eilish A Burke, Dr martin c henman

  38. Prevalence and patterns of anti‐epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities

    Article • Journal of Intellectual Disability Research, January 2018, Wiley

    Dr martin c henman

  39. A test of a new system for providing some intravenous anticancer drugs

    Article • Journal of Oncology Pharmacy Practice, October 2017, SAGE Publications

    Dr martin c henman

  40. Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study

    Article • PLOS One, September 2017, PLOS

    Dr martin c henman

  41. 165Association of Drug Burden Index with Physical Function in Irish Older Adults with Intellectual Disability

    Article • Age and Ageing, September 2017, Oxford University Press (OUP)

    Dr martin c henman

  42. 100Potentially Inappropriate Prescribing of Proton Pump Inhibitors – A Qualitative Study

    Article • Age and Ageing, September 2017, Oxford University Press (OUP)

    Dr martin c henman

  43. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland

    Article • Journal of Intellectual Disability Research, June 2017, Wiley

    Niamh Mulryan, Maire O'Dwyer, Dr martin c henman

  44. Analgesic use by ageing and elderly patients with chronic non-malignant pain: a qualitative study

    Article • International Journal of Clinical Pharmacy, May 2017, Springer Science + Business Media

    Dr martin c henman

  45. Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study

    Article • The British Journal of Psychiatry, December 2016, Royal College of Psychiatrists

    Dr martin c henman

  46. 298 ASSOCIATIONS BETWEEN MEDICATION USE AND FALLS AMONG OLDER ADULTS WITH INTELLECTUAL DISABILITY IN IRELAND

    Article • Age and Ageing, September 2016, Oxford University Press (OUP)

    Dr martin c henman

  47. A retrospective cohort analysis of hypoglycaemic and cardiovascular agent use in young adults in the Irish primary care setting

    Article • Irish Journal of Medical Science (1971 -), August 2016, Springer Science + Business Media

    Dr martin c henman

  48. Terminology, the importance of defining

    Article • International Journal of Clinical Pharmacy, April 2016, Springer Science + Business Media

    Dr martin c henman

  49. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study

    Article • BMJ Open, April 2016, BMJ

    Dr martin c henman

  50. General Practitioners and Chronic Non-Malignant Pain Management in Older Patients: A Qualitative Study

    Article • Pharmacy, March 2016, MDPI AG

    Dr martin c henman

  51. Erratum to: Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

    Article • International Journal of Clinical Pharmacy, March 2016, Springer Science + Business Media

    Prof. Dr. Martin Schulz, Dr martin c henman

  52. The impact of initial antidiabetic agent and use of monitoring agents on prescription costs in newly treated type 2 diabetes: A retrospective cohort analysis

    Article • Diabetes Research and Clinical Practice, March 2016, Elsevier

    Dr martin c henman

  53. ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy

    Article • Journal of Oncology Practice, February 2016, American Society of Clinical Oncology (ASCO)

    Dr martin c henman

  54. Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

    Article • International Journal of Clinical Pharmacy, January 2016, Springer Science + Business Media

    Prof. Dr. Martin Schulz, Dr martin c henman

  55. Building quality indicators for medication use in people aging with intellectual disabilities and behaviour disorders

    Article • International Journal of Developmental Disabilities, January 2016, Maney Publishing

    Dr martin c henman, Bernadette Flood

  56. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice

    Article • Primary Care Diabetes, December 2015, Elsevier

    Dr martin c henman

  57. The Impact Of Self-Monitoring Of Blood Glucose (Smbg) On Prescription Costs In Newly Treated Type 2 Diabetes Melitus (T2dm): A Retrospective Cohort Analysis

    Article • Value in Health, November 2015, Elsevier

    Dr martin c henman

  58. Venlafaxine for neuropathic pain in adults

    Article • Cochrane Database of Systematic Reviews, August 2015, Wiley

    Dr Helen C Gallagher, Dr martin c henman

  59. Hydroxycinnamic acid amide derivatives of polyamines reverse spermine-induced CNS excitation

    Article • Pharmacology Biochemistry and Behavior, June 2015, Elsevier

    Dr martin c henman

  60. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients

    Article • British Journal of Clinical Pharmacology, May 2015, Wiley

    Dr martin c henman

  61. Pharmacists’ medicines-related interventions for people with intellectual disabilities: a narrative review

    Article • International Journal of Clinical Pharmacy, April 2015, Springer Science + Business Media

    Dr martin c henman

  62. Sedative Load and Frailty Among Community-Dwelling Population Aged ≥65 Years

    Article • Journal of the American Medical Directors Association, April 2015, Elsevier

    Dr martin c henman

  63. Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis

    Article • Cancer, February 2015, Wiley

    Dr martin c henman

  64. Case study: hidden complexity of medicines use: information provided by a person with intellectual disability and diabetes to a pharmacist

    Article • British Journal of Learning Disabilities, January 2015, Wiley

    Dr martin c henman, Bernadette Flood

  65. Treatment complications and survival in advanced laryngeal cancer: A population-based analysis

    Article • The Laryngoscope, October 2014, Wiley

    Dr martin c henman

  66. Concurrent Use of Drugs and Supplements in a Community-Dwelling Population Aged 50 Years or More: Potential Benefits and Risks

    Article • Drugs & Aging, June 2014, Springer Science + Business Media

    Dr martin c henman

  67. Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing

    Article • BMC Geriatrics, January 2014, Springer Science + Business Media

    Dr martin c henman

  68. Oral Hypoglycaemic Medicine (OHM) Initiation in Newly Treated Type 2 Diabetes Mellitus (T2DM) in Ireland: An Analysis of Treatment Intensification and Switching Patterns

    Article • Value in Health, November 2013, Elsevier

    Dr martin c henman

  69. Persistence Patterns with Oral Hypoglycaemic Medicines (OHM) in Newly Treated Irish Patients with Type 2 Diabetes Mellitus (T2DM)

    Article • Value in Health, November 2013, Elsevier

    Dr martin c henman

  70. Food supplement use in the community dwelling population aged 50 and over in the Republic of Ireland

    Article • Complementary Therapies in Medicine, August 2013, Elsevier

    Dr martin c henman

  71. Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland

    Article • International Journal of Clinical Pharmacy, September 2012, Springer Science + Business Media

    Dr martin c henman

  72. Costs and trends in pancreatic cancer treatment

    Article • Cancer, March 2012, Wiley

    Dr martin c henman

  73. Provision of pharmaceutical care by community pharmacists: a comparison across Europe

    Article • May 2010, Springer Science + Business Media

    Dr martin c henman, Filipa Costa

  74. Authors' response

    Article • British Journal of General Practice, February 2009, Royal College of General Practitioners

    Dr martin c henman

  75. Over-the-counter cough medicines in children: neither safe or efficacious?

    Article • British Journal of General Practice, November 2008, Royal College of General Practitioners

    Dr martin c henman

  76. The pre-ischaemic neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice

    Article • Brain Research, March 2006, Elsevier

    Dr martin c henman

  77. The pre-ischaemic neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice

    Article • Brain Research, September 2005, Elsevier

    Dr martin c henman

  78. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice

    Article • Brain Research, December 2004, Elsevier

    Dr martin c henman

  79. Drug—Drug Interactions in the Elderly

    Article • Annals of Pharmacotherapy, November 2002, SAGE Publications

    Dr martin c henman

  80. Improving the Well-Being of Elderly Patients via Community Pharmacy-Based Provision of Pharmaceutical Care

    Article • Drugs & Aging, January 2001, Springer Science + Business Media

    Dr martin c henman

  81. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

    Article • Antimicrobial Agents and Chemotherapy, March 1997, ASM Journals

    Dr martin c henman

  82. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species

    Article • Journal of Medical Microbiology, June 1996, Society for General Microbiology

    Prof Gary P Moran, Dr martin c henman

  83. Oral Candida in HIV Infection and AIDS: New Perspectives/New Approaches

    Article • Critical Reviews in Microbiology, January 1993, Taylor & Francis

    Dr martin c henman, David C Coleman

  84. Evaluation of Dandelion for Diuretic Activity and Variation in Potassium Content

    Article • Pharmaceutical Biology, January 1993, Taylor & Francis

    Dr martin c henman

  85. Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation

    Article • Journal of General Microbiology, September 1992, Society for General Microbiology

    Dr martin c henman

  86. Impact of a Nationwide Limited Prescribing List: Preliminary Findings

    Article • Drug Intelligence & Clinical Pharmacy, July 1987, SAGE Publications

    Dr martin c henman

  87. A SURVEY OF DRUG AND THERAPEUTICS COMMITTEES OPERATING IN IRELAND

    Article • Journal of Clinical Pharmacy and Therapeutics, April 1986, Hindawi Publishing Corporation

    Dr martin c henman

  88. Comparison of bioassay methods for the estimation of wound-released prostaglandin-like activity

    Article • Journal of Pharmacological Methods, February 1983, Elsevier

    Dr martin c henman

  89. Effect of Topical Antisepsis Agents on the Release of Prostaglandin-Like Activity from Skin Wounds in Guinea Pigs and Rabbits

    Article • Journal of Toxicology Cutaneous and Ocular Toxicology, January 1983, Taylor & Francis

    Dr martin c henman

  90. A critical evaluation of the use of a cascade superfusion technique for the detection and estimation of biological activity

    Article • Journal of Pharmacological Methods, June 1978, Elsevier

    Dr martin c henman